Showing results (131-140 of 177) with videos related to

Sort By:
Pageof 18
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 3, 2024
Minimal Residual Disease Status in Multiple Myeloma 1 Year After Autologous Hematopoietic Cell Transplantation and Lenalidomide Maintenance Are Associated With Long-Term Overall SurvivalMarcelo C Pasquini, Paul K Wallace, Brent Logan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 7, 2012
Phase II trial of parathyroid hormone after double umbilical cord blood transplantationKaren Ballen, Adam M Mendizabal, Corey Cutler, et al.
Blood|October 4, 2018
Small-molecule BCL6 inhibitor effectively treats mice with nonsclerodermatous chronic graft-versus-host diseaseKatelyn Paz, Ryan Flynn, Jing Du, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 15, 2015
Hematopoietic Stem Cell Transplantation for Multiple Myeloma: Guidelines from the American Society for Blood and Marrow TransplantationNina Shah, Natalie Callander, Siddhartha Ganguly, et al.
Bone Marrow Transplantation|March 5, 2024
Harmonizing definitions for hematopoietic recovery, graft rejection, graft failure, poor graft function, and donor chimerism in allogeneic hematopoietic cell transplantation: a report on behalf of the EBMT, ASTCT, CIBMTR, and APBMTAnna Sureda, Paul A Carpenter, Andrea Bacigalupo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 18, 2019
Autologous Transplantation, Consolidation, and Maintenance Therapy in Multiple Myeloma: Results of the BMT CTN 0702 TrialEdward A Stadtmauer, Marcelo C Pasquini, Beth Blackwell, et al.
Transplantation and Cellular Therapy|April 20, 2021
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2020 Etiology and Prevention Working Group ReportKirsten M Williams, Yoshihiro Inamoto, Annie Im, et al.
Research Square|April 2, 2024
Nonpathogenic <i>E. coli</i> engineered to surface display cytokines as a new platform for immunotherapyShaobo Yang, Michal Sheffer, Isabel E Kaplan, et al.
Blood|March 14, 2022
Impact of diagnostic genetics on remission MRD and transplantation outcomes in older patients with AMLH Moses Murdock, Haesook T Kim, Nathan Denlinger, et al.
Blood Advances|November 22, 2021
GM-CSF secreting leukemia cell vaccination for MDS/AML after allogeneic HSCT: a randomized, double-blinded, phase 2 trialVincent T Ho, Haesook T Kim, Jennifer Brock, et al.
Pageof 18